Genetics of retinoblastoma

References

• Devesa SS. The incidence of retinoblastoma. Am. J. Ophthalmol.80, 263–265 (1975).
   PubMed Web of Science ®Google Scholar
• Leal-Leal C, Flores-Rojo M, Medina-Sanson A et al. A multicentre report from the Mexican Retinblastoma Group. Br. J. Ophthalmol.88, 1074–1077 (2004).
   PubMed Web of Science ®Google Scholar
• Krishna SM, Yu GP, Finger PT. The effect of race on the incidence of retinoblastoma. J. Pediatr. Ophthalmol. Strabismus46, 288–293 (2009).
   PubMedGoogle Scholar
• Albert DM. Historic review of retinoblastoma. Ophthalmology94, 654–662 (1987).
   PubMedGoogle Scholar
• DiCiommo D, Gallie BL, Bremmer R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin. Cancer Biol.10, 255–269 (2000).
   PubMed Web of Science ®Google Scholar
• Draper GJ, Sanders BM, Brownbill PA, Hawkins MM. Patterns of risk of hereditary and applications to genetic counselling. Br. J. Cancer66, 211–219 (1992).
   PubMedGoogle Scholar
• Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA68, 820–823 (1971).
   PubMed Web of Science ®Google Scholar
• Vogel F. Genetics of retinoblastoma. Hum. Genet.52, 1–54 (1979).
   PubMed Web of Science ®Google Scholar
• Gallie BL. Predictive testing for retinoblastoma comes of age. Am. J. Hum. Genet.61, 279–281 (1997).
   PubMedGoogle Scholar
• Cohen J, Dryja TP, Davis KB, Diller LR, Li FP. RB1 genetic testing as a clinical service: a follow-up study. Med. Pediatr. Oncol.37, 372–378 (2001).
   PubMedGoogle Scholar
• Raizis A, Clemett R, Corbett R et al. Improved clinical management of retinoblastoma through gene testing. NZ Med. J.115, 231–234 (2001).
   Google Scholar
• Doz F. Retinoblastoma: a review. Arch. Pediatr.13, 1329–1337 (2006).
   PubMed Web of Science ®Google Scholar
• Cowell JK, Gallie BL. Which retinoblastoma patients should be screened for RB1 mutations? Eur. J. Cancer34, 1825–1826 (1998).
   PubMedGoogle Scholar
• Xu K, Rosenwaks Z, Beaverson K et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn. Am. J. Ophthalmol.137, 18–23 (2004).
   PubMed Web of Science ®Google Scholar
• Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J. Natl Cancer Inst. Monogr.34, 87–90 (2005).
   PubMedGoogle Scholar
• Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med. Pediatr. Oncol.38, 411–415 (2002).
   PubMedGoogle Scholar
• Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch. Ophthalmol.120, 1653–1658 (2002).
   PubMedGoogle Scholar
• Zage PE, Reitman AJ, Seshadri R et al. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatr. Blood Cancer50, 567–572 (2008).
   PubMed Web of Science ®Google Scholar
• Shields JA, Schields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am. J. Ophthalmol.140, 505–506 (2005).
   PubMedGoogle Scholar
• Shields CL, Mashayekhi A, Au AK et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology113, 2276–2280 (2006).
   PubMed Web of Science ®Google Scholar
• Chantada GL, Doz F, Orjuela M et al. World disparties in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr. Blood Cancer50, 692–694 (2008).
   PubMed Web of Science ®Google Scholar
• Valverde JR, Alonso J, Palacios I, Pestana A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet.6, 53 (2005).
   PubMed Web of Science ®Google Scholar
• Lohmann DR. RB1 gene mutations in retinoblastoma. Hum. Mut.14, 283–288 (1999).
   PubMed Web of Science ®Google Scholar
• Harbour JW. Overview of RB gene mutations in patients with retinoblastoma. Ophthalmology105, 1442–1447 (1998).
   PubMed Web of Science ®Google Scholar
• Richter S, Vandezande K, Chen K et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am. J. Hum. Genet.72, 253–269 (2003).
   PubMed Web of Science ®Google Scholar
• Houdayer C, Gauthier-Villars M, Laugé A et al. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum. Mutat.23, 193–202 (2004).
   PubMed Web of Science ®Google Scholar
• Alonso J, Garcia-Miguel P, Abelairas J et al. Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients : phenotypic and molecular epidemiological implications. Hum. Mutat.17, 412–422 (2001).
   PubMedGoogle Scholar
• Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat. Cell. Biol.94, E65–E67 (2000).
   Google Scholar
• Schüler A, Weber S, Neuhäuser M et al. Age at diagnosis of isolated unilateral retinoblastoma does not distinguish patients with and without a constitutional RB1 gene mutation but is influenced by a parent-of-origin effect. Eur. J. Cancer41, 735–740 (2005).
   PubMedGoogle Scholar
• Dryja TP, Mukai S, Petersen R et al. Parental origin of mutations of the retinoblastoma gene. Nature339, 556–558 (1989).
   PubMed Web of Science ®Google Scholar
• Zhu XP, Dunn JM, Philips RA et al. Preferential germline mutation of the paternal allele in retinoblastoma. Nature340, 312–313 (1989).
   PubMed Web of Science ®Google Scholar
• Nichols KE, Houseknecht MD, Godmilow L et al. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novels mutations in the RB1 gene. Hum. Mutat.25, 566–574 (2005).
   PubMedGoogle Scholar
• Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist12, 1237–1246 (2007).
   PubMed Web of Science ®Google Scholar
• Lohmann DR, Gallie BL. Retinoblastoma: revisiting the model prototype of inherited cancer. Am. J. Med. Genet. C Semin. Med. Genet.129C, 23–28 (2004).
   PubMed Web of Science ®Google Scholar
• Tsai T, Fulton L, Smith BJ et al. Rapid identification of germline mutations in retinoblastoma by protein truncation testing. Arch. Ophthalmol.122, 239–248 (2004).
   PubMedGoogle Scholar
• Dalamon V, Surace E, Borelina D et al. Detection of mutations in Argentine retinoblastoma patients by segregation of polymorphisms, exon analysis and cytogenetic tests. Ophthalmic. Res.33, 336–339 (2001).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Toguchida J, Kato MV, Kaneko A, Ishizaki K, Sasaki MS. Detection of mutations of the RB1 gene in retinoblastoma patients by using exon-by-exon PCR-SSCP analysis. Am. J. Hum. Genet.54, 793–800 (1994).
   PubMedGoogle Scholar
• Lohmann D, Horsthemke B, Gillessen-Kaesbach G, Stefani FH, Höfler H. Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis. Hum. Genet.89, 49–53 (1992).
   PubMedGoogle Scholar
• Bonaiti-Pellie C, Colombies P, Bec P, Briard-Guillemot ML, Feingold J, Frezal J. Prevalence of retinoblastoma in the Midi-Pyrenees area. Ann. Genet.18, 223–226 (1975).
   PubMedGoogle Scholar
• Jakubowska A, Zajaczek S, Haus O et al. Novel RB1 gene constitutional mutations found in Polish patients with familial and/or bilateral retinoblastoma. Hum. Mut.18, 459 (2001).
   PubMedGoogle Scholar
• Blanquet V, Turleau C, Gross-Morand MS, Sénamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum. Mol. Genet.4, 383–388 (1995).
   PubMed Web of Science ®Google Scholar
• Zeschnigk M, Böhringer S, Price EA, Onadim Z, Masshöfer DR, Lohmann DR. A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res.32, 1–5 (2004).
   PubMedGoogle Scholar
• Yu YS, Kim IJ, Ku JL, Park JG. Identification of four novel RB germline mutations in Korean retinoblastoma patients. Hum. Mut.18, 252 (2001).
   PubMedGoogle Scholar
• Ata-ur-Rasheed M, Vemuganti GK, Honavar SG, Ahmed N, Hasnain SE, Kannabiran C. Mutational analysis of the RB1 gene in Indian patients with retinoblastoma. Ophthalmic Genet.23, 121–128 (2002).
   PubMedGoogle Scholar
• Leone PE, Vega ME, Jervis P, Pestana A, Alonso J, Paz-y-Mino C. Two new mutations and three novel polymorphisms in the RB1 gene in Ecuadorian patients. J. Hum. Genet.18, 639–641 (2003).
   Google Scholar
• Kumaramanickavel G, Joseph B, Narayana K et al. Molecular-genetic analysis of two cases with retinoblastoma: benefits for disease management. J. Genet.82, 39–44 (2003).
   PubMedGoogle Scholar
• Zajaczek S, Jakubowska A, Kurzawski G, Krzystolik Z, Lubinski J. Age at diagnosis to discriminate those patients for whom constitutional DNA sequencing is appropriate in sporadic unilateral retinoblastoma. Eur. J. Cancer34, 1919–1921 (1998).
   PubMedGoogle Scholar
• Brichard B, Heusterspreute M, De Potter P et al. Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation. Eur. J. Cancer42, 65–72 (2006).
   PubMedGoogle Scholar
• Cowell JK, Smith T, Bia B. Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma. Eur. J. Hum. Genet.2, 281–290 (1994).
   PubMedGoogle Scholar
• Rushlow D, Piovesan B, Zhang K et al. Detection of mosaic RB1 mutations in families with retinoblastoma. Hum. Mutat.30, 842–851 (2009).
   PubMed Web of Science ®Google Scholar
• Dehainault C, Michaux D, Pagès-Berhouet S et al. A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation. Eur. J. Hum. Genet.15, 473–477 (2007).
   PubMed Web of Science ®Google Scholar
• Sellner LN, Edkins E, Smith N. Screening for RB1 mutations in tumour tissue using denaturating high performance liquid chromatography, multiplex ligation-dependant probe amplification, and loss of heterozygosity analysis. Pediatr. Dev. Pathol.9, 31–37 (2006).
   PubMedGoogle Scholar
• Zhang K, Nowak I, Rushlow D, Gallie BL, Lohmann DR. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression. Hum. Mutat.29, 475–484 (2008).
   PubMed Web of Science ®Google Scholar
• Brichard B, Chantrain C, Gala JL, Sibille C, Vermylen C, De Potter P. Retinoblastoma and deletion of the long arm of chromosome 13: an underestimated diagnosis? Pediatr. Blood Cancer50, 694–696 (2008).
   PubMedGoogle Scholar
• Albrechts P, Ansperger-Rescher B, Schüler A et al. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Hum. Mutat.26, 437–445 (2006).
   Google Scholar
• Lin P, O’Brien JM. Frontiers in the management of retinoblastoma. Am. J. Ophthalmol.148, 192–198 (2009).
   PubMed Web of Science ®Google Scholar
• Musarella MA, Gallie BL. A simplified scheme for genetic counseling in retinoblastoma. J. Pediatr. Ophthalmol. Strabismus24, 124–125 (1987).
   PubMedGoogle Scholar
• Taylor M, Dehainault C, Desjardins L et al. Genotype–phenotype correlations in hereditary familial retinoblastoma. Hum. Mut.28, 284–293 (2007).
   PubMed Web of Science ®Google Scholar
• Harbour JW. Molecular basis of low-penetrance retinoblastoma. Arch. Ophthalmol.119, 1699–1704 (2001).
   PubMedGoogle Scholar
• Lohmann DR, Brandt B, Höpping W, Passarge E, Horsthemke B. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum. Genet.94, 349–954 (1994).
   PubMed Web of Science ®Google Scholar
• Bremner R, Du DC, Connolly-Wilson MJ et al. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am. J. Hum. Genet.61, 556–570 (1997).
   PubMedGoogle Scholar
• Leiderman YI, Kiss S. Mukai S. Molecular genetics of RB1 – the retinoblastoma gene. Semin. Ophthalmol.22, 247–254 (2007).
   PubMedGoogle Scholar
• Klutz M, Brockmann D, Lohmann DR. A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene. Am. J. Hum. Genet.71, 174–179 (2002).
   PubMedGoogle Scholar
• Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology95, 1583–1587 (1988).
   PubMed Web of Science ®Google Scholar
• Kleinerman RA, Tucker MA, Tarone RE et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J. Clin. Oncol.23, 2272–2279 (2005).
   PubMed Web of Science ®Google Scholar
• Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J. Natl. Cancer Inst.100, 1771–1779 (2008).
   PubMed Web of Science ®Google Scholar
• Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni JF Jr. Risk of soft tissue sarcomas by individuals subtype in survivors of hereditary retinoblastoma. J. Natl. Cancer Inst.99, 24–31 (2007).
   PubMed Web of Science ®Google Scholar
• Sheen V, Tucker MA, Abramson DH, Seddon JM, Kleinerman RA. Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer113, 434–441 (2008).
   PubMed Web of Science ®Google Scholar
• Alvarez CS. Molecular biology of retinoblastoma. Clin. Trans. Oncol.10, 389–394 (2008).
   PubMedGoogle Scholar
• Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr. Opin. Ophthalmol.20, 351–355 (2009).
   PubMed Web of Science ®Google Scholar
• Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer36, 121–128 (2007).
   Google Scholar
• Gratias S, Rieder H, Ullmann R et al. Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma. Cancer Res.67, 408–416 (2007).
   PubMedGoogle Scholar
• Mastrangelo D, De Francesco S, Di Leonardo A, Lentini L, Hadjistilianou T. Does the evidence matter in medicine? The retinoblastoma paradigm. Int. J. Cancer120, 2501–2505 (2007).
   Google Scholar
• MacPherson D, Dyer MA. Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy. Cancer Res.67, 7547–7550 (2007).
   PubMed Web of Science ®Google Scholar
• MacPherson D, Conkrite K, Tam M, Mukai S, Mu D, Jacks T. Murine bilateral retinoblastoma exhibiting rapid-onset, metastasic progression and N-Myc gene amplification. EMBO J.26, 784–794 (2007).
   PubMed Web of Science ®Google Scholar
• Laurie NA, Donovan SL, Shih CS et al. Inactivation of the p53 pathway in retinoblastoma. Nature444, 61–66 (2006).
   PubMed Web of Science ®Google Scholar
• Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett.420, 25–27 (1997).
   PubMed Web of Science ®Google Scholar
• Xu XL, Fang Y, Lee TC et al. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell137, 1018–1031 (2009).
   PubMedGoogle Scholar
• Elison JR, Cobrinik D, Claros N, Abramson DH, Lee TC. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells. Arch. Ophthalmol.124, 1269–1275 (2006).
   PubMed Web of Science ®Google Scholar
• Stephan H, Zakrzewski Jl, Bölöni R, Grasemann C, Lohmann DR, Eggert A. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines. Pediatr. Blood Cancer50, 218–222 (2008).
   PubMedGoogle Scholar
• Poulaki V, Mitsiades CS, Kotoula V et al. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell mines in vitro. Invest. Ophthalmol. Vis. Sci.48, 4706–4719 (2007).
   PubMed Web of Science ®Google Scholar